CRISPR Therapeutics AG (CRSP) is in Healthcare, Biotechnology, based in Switzerland, listed on NasdaqGM. Market cap 4.91B USD. 52-week range 44.12 to 78.00 USD. Data as of 2026-10-09.
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell ...